Long non-coding rna regulation of epithelial– mesenchymal transition in cancer metastasis

Cell Death and Disease

Volumn 7, Issue 6, 2016, Pages

  Xu, Q ^a,b   Deng, F ^c   Qin, Y ^b   Zhao, Z ^a   Wu, Z ^b   Xing, Z ^c   Ji, A ^b   Wang, Q J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; HYPOXIA INDUCIBLE FACTOR 1; LONG UNTRANSLATED RNA; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

CANCER DIAGNOSIS; CANCER PROGNOSIS; EPITHELIAL MESENCHYMAL TRANSITION; HEDGEHOG SIGNALING; HUMAN; MALIGNANT NEOPLASM; MAPK SIGNALING; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; WNT SIGNALING; ANIMAL; BIOLOGICAL MODEL; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 85011095959     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.149     Document Type: Review

References (102)

1. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011; 331: 1559–1564.
2. Nieto MA. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 2013; 342: 1234850.
3. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871–890.
4. Serviss JT, Johnsson P, Grander D. An emerging role for long non-coding RNAs in cancer metastasis. Front Genet 2014; 5: 234.
5. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13: 97–110.
6. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008; 65: 3756–3788.
7. Chan SH, Wang LH. Regulation of cancer metastasis by microRNAs. J Biomed Sci 2015; 22: 9.
8. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429–1437.
9. Sanchez-Tillo E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M et al. EMT-activating transcription factors in cancer: beyond EMTand tumor invasiveness. Cell Mol Life Sci 2012; 69: 3429–3456.
10. Brunen D, Willems SM, Kellner U, Midgley R, Simon I, Bernards R. TGF-beta: an emerging player in drug resistance. Cell Cycle 2013; 12: 2960–2968.
11. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178–196.
12. Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res 2009; 19: 128–139.
13. Yu L, Hebert MC, Zhang YE. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 2002; 21: 3749–3759.
14. Grande M, Franzen A, Karlsson JO, Ericson LE, Heldin NE, Nilsson M. Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 2002; 115(Pt 22): 4227–4236.
15. Garg M. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer. Expert Opin Ther Targets 2015; 19: 285–297.
16. Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH et al. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 2006; 8: 1398–1406.
17. Howe LR, Watanabe O, Leonard J, Brown AM. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res 2003; 63: 1906–1913.
18. Bailey JM, Mohr AM, Hollingsworth MA. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 2009; 28: 3513–3525.
19. Wang F, Ma L, Zhang Z, Liu X, Gao H, Zhuang Y et al. Hedgehog signaling regulates epithelial-mesenchymal transition in pancreatic cancer stem-like cells. J Cancer 2016; 7: 408–417.
20. Katoh M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 2007; 3: 30–38.
21. Bao B, Azmi AS, Ali S, Ahmad A, Li Y, Banerjee S et al. The biological kinship of hypoxia with CSC and EMTand their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta 2012; 1826: 272–296.
22. Lundgren K, Nordenskjold B, Landberg G. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer 2009; 101: 1769–1781.
23. Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH et al. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 2006; 66: 2725–2731.
24. Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008; 27: 6958–6969.
25. Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell 2011; 145: 178–181.
26. Guo F, Parker Kerrigan BC, Yang D, Hu L, Shmulevich I, Sood AK et al. Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions. J Hematol Oncol 2014; 7: 19.
27. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704–715.
28. Meseure D, Drak Alsibai K, Nicolas A, Bieche I, Morillon A. Long noncoding RNAs as new architects in cancer epigenetics, prognostic biomarkers, and potential therapeutic targets. Biomed Res Int 2015; 2015: 320214.
29. Malek E, Jagannathan S, Driscoll JJ. Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget 2014; 5: 8027–8038.
30. Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014; 505: 344–352.
31. Zhang H, Liu L, Wang Y, Zhao G, Xie R, Liu C et al. KLF8 involves in TGF-beta-induced EMTand promotes invasion and migration in gastric cancer cells. J Cancer Res Clin Oncol 2013; 139: 1033–1042.
32. Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014; 25: 666–681.
33. Saito T, Kurashige J, Nambara S, Komatsu H, Hirata H, Ueda M et al. A long non-coding RNA activated by transforming growth factor-beta is an independent prognostic marker of gastric cancer. Ann Surg Oncol 2015; 22(Suppl 3): S915–S922.
34. Iguchi T, Uchi R, Nambara S, Saito T, Komatsu H, Hirata H et al. A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Anticancer Res 2015; 35: 1385–1388.
35. Li W, Kang Y. A new Lnc in metastasis: long noncoding RNA mediates the prometastatic functions of TGF-beta. Cancer Cell 2014; 25: 557–559.
36. Shi SJ, Wang LJ, Yu B, Li YH, Jin Y, Bai XZ. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget 2015; 6: 11652–11663.
37. Yue B, Qiu S, Zhao S, Liu C, Zhang D, Yu F et al. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis. J Gastroenterol Hepatol 2015; 31: 595–603.
38. Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F et al. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res 2014; 20: 1531–1541.
39. Zhuang J, Lu Q, Shen B, Huang X, Shen L, Zheng X et al. TGFbeta1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. Sci Rep 2015; 5: 11924.
40. Richards EJ, Zhang G, Li ZP, Permuth-Wey J, Challa S, Li Y et al. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) beta: LncRNA-hit-mediated TGFbeta-induced epithelial to mesenchymal transition in mammary epithelia. J Biol Chem 2015; 290: 6857–6867.
41. Matouk IJ, Raveh E, Abu-lail R, Mezan S, Gilon M, Gershtain E et al. Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta 2014; 1843: 1414–1426.
42. Matouk IJ, Mezan S, Mizrahi A, Ohana P, Abu-Lail R, Fellig Y et al. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim Biophys Acta 2010; 1803: 443–451.
43. Takahashi K, Yan IK, Haga H, Patel T. Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci 2014; 127(Pt 7): 1585–1594.
44. Zhou X, Chen J, Tang W. The molecular mechanism of HOTAIR in tumorigenesis, metastasis, and drug resistance. Acta Biochim Biophys Sin (Shanghai) 2014; 46: 1011–1015.
45. Wu ZH, Wang XL, Tang HM, Jiang T, Chen J, Lu S et al. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep 2014; 32: 395–402.
46. Ge XS, Ma HJ, Zheng XH, Ruan HL, Liao XY, Xue WQ et al. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci 2013; 104: 1675–1682.
47. Han Y, Liu Y, Nie L, Gui Y, Cai Z. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Urology 2013; 81: 209.e201–207.
48. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst 2012; 8: 2289–2294.
49. Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 2013; 333: 213–221.
50. Leicht DT, Balan V, Kaplun A, Singh-Gupta V, Kaplun L, Dobson M et al. Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta 2007; 1773: 1196–1212.
51. Guo Q, Zhao Y, Chen J, Hu J, Wang S, Zhang D et al. BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition. Oncol Lett 2014; 8: 869–875.
52. Chen F, Tian Y, Pang EJ, Wang Y, Li L. MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer. Cancer Gene Ther 2015 (advance online publication; doi:10.1002/mc.22338).
53. Zhou M, Hou Y, Yang G, Zhang H, Tu G, Du YE et al. LncRNA-Hh strengthen cancer stem cells generation in twist-positive breast cancer via activation of hedgehog signaling pathway. Stem Cells 2016; 34: 55–66.
54. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 2008; 27: 7274–7284.
55. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 2009; 106: 11667–11672.
56. Davidovich C, Zheng L, Goodrich KJ, Cech TR. Promiscuous RNA binding by Polycomb repressive complex 2. Nat Struct Mol Biol 2013; 20: 1250–1257.
57. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071–1076.
58. Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, Takamaru H et al. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 2012; 72: 1126–1136.
59. Geng YJ, Xie SL, Li Q, Ma J, Wang GY. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res 2011; 39: 2119–2128.
60. He W, Cai Q, Sun F, Zhong G, Wang P, Liu H et al. linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer. Biochim Biophys Acta 2013; 1832: 1528–1537.
61. Sun NX, Ye C, Zhao Q, Zhang Q, Xu C, Wang SB et al. Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer. PLoS One 2014; 9: e100340.
62. Sun M, Liu XH, Lu KH, Nie FQ, Xia R, Kong R et al. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis 2014; 5: e1298.
63. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK et al. Natural RNA circles function as efficient microRNA sponges. Nature 2013; 495: 384–388.
64. Saito Y, Suzuki H, Matsuura M, Sato A, Kasai Y, Yamada K et al. MicroRNAs in Hepatobiliary and Pancreatic Cancers. Front Genet 2011; 2: 66.
65. Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z et al. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumour Biol 2014; 35: 9163–9169.
66. Liang WC, Fu WM, Wong CW, Wang Y, Wang WM, Hu GX et al. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget 2015; 6: 22513–22525.
67. Zhou X, Ye F, Yin C, Zhuang Y, Yue G, Zhang G. The interaction between MiR-141 and lncRNA-H19 in regulating cell proliferation and migration in gastric cancer. Cell Physiol Biochem 2015; 36: 1440–1452.
68. Carpenter RL, Paw I, Dewhirst MW, Lo HW. Akt phosphorylates and activates HSF-1 independent of heat shock, leading to Slug overexpression and epithelial-mesenchymal transition (EMT) of HER2-overexpressing breast cancer cells. Oncogene 2015; 34: 546–557.
69. Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer 2014; 13: 92.
70. Liu YW, Sun M, Xia R, Zhang EB, Liu XH, Zhang ZH et al. Linc HOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer. Cell Death Dis 2015; 6: e1802.
71. Li JT, Wang LF, Zhao YL, Yang T, Li W, Zhao J et al. Nuclear factor of activated T cells 5 maintained by HOTAIR suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis. Breast Cancer Res 2014; 16: 454.
72. Inamoto T, Taniguchi K, Takahara K, Iwatsuki A, Takai T, Komura K et al. Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft. Oncotarget 2015; 6: 21628–21635.
73. Tan J, Qiu K, Li M, Liang Y. Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells. FEBS Lett 2015; 589(20 Pt B): 3175–3181.
74. Cong N, Du P, Zhang A, Shen F, Su J, Pu P et al. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/beta-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep 2013; 29: 1579–1587.
75. Xue M, Pang H, Li X, Li H, Pan J, Chen W. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci 2016; 107: 18–27.
76. Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y et al. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis 2014; 5: e1287.
77. Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta 2015; 1859: 169–176.
78. Han Y, Ye J, Wu D, Wu P, Chen Z, Chen J et al. LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition. BMC Cancer 2014; 14: 932.
79. Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ, Huang L et al. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci 2013; 9: 587–597.
80. Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z et al. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene 2015; 35: 1575–1584.
81. Ye P, Wang T, Liu WH, Li XC, Tang LJ, Tian FZ. Enhancing HOTAIR/MiR-10b drives normal liver stem cells toward a tendency to malignant transformation through inducing epithelial-to-mesenchymal transition. Rejuvenation Res 2015; 18: 332–340.
82. Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang Y, Tang GN et al. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology 2013; 57: 1882–1892.
83. Wang TH, Lin YS, Chen Y, Yeh CT, Huang YL, Hsieh TH et al. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transitionl. Oncotarget 2015; 6: 23342–23357.
84. Zhao J, Liu Y, Zhang W, Zhou Z, Wu J, Cui P et al. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer. Cell Cycle 2015; 14: 3112–3123.
85. Sun M, Liu XH, Wang KM, Nie FQ, Kong R, Yang JS et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer 2014; 13: 68.
86. Wu Y, Huang C, Meng X, Li J. Long noncoding RNA MALAT1insights into its biogenesis and implications in human disease. Curr Pharm Des 2015; 21: 5017–5028.
87. Shen L, Chen L, Wang Y, Jiang X, Xia H, Zhuang Z. Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer. J Neurooncol 2015; 121: 101–108.
88. Xie M, Nie FQ, Sun M, Xia R, Liu YW, Zhou P et al. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition. J Transl Med 2015; 13: 250.
89. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007; 132: 330–342.
90. Xie H, Ma H, Zhou D. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int 2013; 2013: 136106.
91. Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H, Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol 2009; 21: 688–692.
92. Zhao Y, Guo Q, Chen J, Hu J, Wang S, Sun Y. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep 2014; 31: 358–364.
93. Pasquier J, Abu-Kaoud N, Al Thani H, Rafii A. Epithelial to mesenchymal transition in a clinical perspective. J Oncol 2015; 2015: 792182.
94. Zeng S, Xiao YF, Tang B, Hu CJ, Xie R, Yang SM et al. Long noncoding RNA in digestive tract cancers: function, mechanism, and potential biomarker. Oncologist 2015; 20: 898–906.
95. Pauli A, Montague TG, Lennox KA, Behlke MA, Schier AF. Antisense oligonucleotide-mediated transcript knockdown in zebrafish. PLoS One 2015; 10: e0139504.
96. Wheeler TM, Leger AJ, Pandey SK, MacLeod AR, Nakamori M, Cheng SH et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 2012; 488: 111–115.
97. Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013; 73: 1180–1189.
98. Ma L, Chua MS, Andrisani O, So S. Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. World J Gastroenterol 2014; 20: 333–345.
99. Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 2011; 71: 3–7.
100. Li H, Zhu L, Xu L, Qin K, Liu C, Yu Y et al. Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer. Mol Carcinog 2015.
101. Wu J, Zhang J, Shen B, Yin K, Xu J, Gao W et al. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. J Exp Clin Cancer Res 2015; 34: 116.
102. Lv W, Wang L, Lu J, Mu J, Liu Y, Dong P. Long noncoding RNA KIAA0125 potentiates cell migration and invasion in gallbladder cancer. Biomed Res Int 2015; 2015: 108458.